Hartford Investment Management Co. Sells 1,226 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Hartford Investment Management Co. trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 56,893 shares of the healthcare conglomerate’s stock after selling 1,226 shares during the period. UnitedHealth Group accounts for about 0.9% of Hartford Investment Management Co.’s investment portfolio, making the stock its 15th biggest holding. Hartford Investment Management Co.’s holdings in UnitedHealth Group were worth $28,780,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of UNH. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $30,000. RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group in the third quarter worth $37,000. Friedenthal Financial acquired a new position in shares of UnitedHealth Group during the 3rd quarter worth about $51,000. DecisionPoint Financial LLC increased its position in shares of UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after purchasing an additional 62 shares during the last quarter. Finally, Highline Wealth Partners LLC bought a new position in shares of UnitedHealth Group in the third quarter valued at $55,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on UNH. Bank of America lowered their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Royal Bank of Canada cut their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. UBS Group dropped their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Up 0.1 %

Shares of UNH opened at $533.99 on Wednesday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The firm has a 50 day simple moving average of $527.67 and a two-hundred day simple moving average of $564.22. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market cap of $491.42 billion, a P/E ratio of 34.45, a P/E/G ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. During the same period last year, the firm posted $5.83 earnings per share. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.